Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Nov 24;12(2):235–244. doi: 10.1111/1759-7714.13754

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Kaplan‐Meier plots for freedom from recurrence according to S/MP subtype component. (a) S/MP+ vs. S/MP− , S/MP−; , S/MP+, (b) S/MP+ vs. S/MP− in each stage , Stage IA S/MP−; , Stage IA S/MP+; , Stage IB S/MP−; , Stage IB S/MP+; , Stage II–IIIA S/MP−; , Stage II–IIIA S/MP+, (c) S/MP5 vs. S/MP− , S/MP−; , S/MP5, (d) Comparison of S/MP+ vs. S/MP− and IB vs. IA in stage I , Stage IA; , Stage IB; , Stage I S/MP−; , Stage I S/MP+, (e) S/MP5 vs. S/MP− in stage IA , Stage IA S/MP−; , Stage IA S/MP5. MP, micropapillary; S, solid; S/MP+, solid or micropapillary subtype present; S/MP−, both solid and micropapillary subtype absent; S/MP5, solid or micropapillary subtype proportion of 5% or less. P‐values by log‐rank test and hazard ratio (HR) and 95% confidence interval (CI) estimated by univariate Cox model.

Inline graphic — Kaplan‐Meier plots for freedom from recurrence according to S/MP subtype component. (a) S/MP+ vs. S/MP− , S/MP−; , S/MP+, (b) S/MP+ vs. S/MP− in each stage , Stage IA S/MP−; , Stage IA S/MP+; , Stage IB S/MP−; , Stage IB S/MP+; , Stage II–IIIA S/MP−; , Stage II–IIIA S/MP+, (c) S/MP5 vs. S/MP− , S/MP−; , S/MP5, (d) Comparison of S/MP+ vs. S/MP− and IB vs. IA in stage I , Stage IA; , Stage IB; , Stage I S/MP−; , Stage I S/MP+, (e) S/MP5 vs. S/MP− in stage IA , Stage IA S/MP−; , Stage IA S/MP5. MP, micropapillary; S, solid; S/MP+, solid or micropapillary subtype present; S/MP−, both solid and micropapillary subtype absent; S/MP5, solid or micropapillary subtype proportion of 5% or less. P‐values by log‐rank test and hazard ratio (HR) and 95% confidence interval (CI) estimated by univariate Cox model.